AB Science Eulerpool Ziņas

AB Science Akciju Ziņas

AB Science tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās AB Science ziņas mēs apkopojam šeit.

• 28. oktobris ·

  Yahoo
  AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease
• 10. oktobris ·

  Yahoo
  AB Science: Revenues for the first half of 2024 and update on AB Science’s activities
• 30. septembris ·

  Yahoo
  AB Science announces a slight delay in the publication of its 2024 half-year financial report
• 26. septembris ·

  Yahoo
  AB Science provides an update on the microtubule program AB8939 and in particular the ability of AB8939 to generate response on MECOM rearrangement
• 23. septembris ·

  Yahoo
  AB Science provides an update on the development of masitinib in progressive forms of multiple sclerosis post ECTRIMS 2024
• 8. jūlijs ·

  Yahoo
  AB Science touts positive Phase II Covid-19 data for masitinib
• 8. jūlijs ·

  Yahoo
  AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19
• 28. jūnijs ·

  Yahoo
  AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
• 11. marts ·

  Nasdaq
  Why Veon Stock Was Up on a Down Day for the S&P 500
• 8. marts ·

  Nasdaq
  Why Nvidia, Micron, and AMD Stocks Popped Tuesday